Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference

Key Takeaway: Vir Biotechnology will participate in the Bank of America Securities 2026 Healthcare Conference. This event provides a platform for the company to discuss its strategies and advancements in biotechnology. Further details about the conference agenda and Vir's specific contributions are yet to be announced.